GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Arcadia Biosciences Inc (NAS:RKDA) » Definitions » Cyclically Adjusted PS Ratio

RKDA (Arcadia Biosciences) Cyclically Adjusted PS Ratio : 0.12 (As of Dec. 14, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Arcadia Biosciences Cyclically Adjusted PS Ratio?

As of today (2024-12-14), Arcadia Biosciences's current share price is $6.30. Arcadia Biosciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was $53.05. Arcadia Biosciences's Cyclically Adjusted PS Ratio for today is 0.12.

The historical rank and industry rank for Arcadia Biosciences's Cyclically Adjusted PS Ratio or its related term are showing as below:

RKDA' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.03   Med: 0.05   Max: 0.12
Current: 0.12

During the past years, Arcadia Biosciences's highest Cyclically Adjusted PS Ratio was 0.12. The lowest was 0.03. And the median was 0.05.

RKDA's Cyclically Adjusted PS Ratio is ranked better than
94.13% of 1226 companies
in the Consumer Packaged Goods industry
Industry Median: 0.9 vs RKDA: 0.12

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Arcadia Biosciences's adjusted revenue per share data for the three months ended in Sep. 2024 was $1.127. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $53.05 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Arcadia Biosciences Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Arcadia Biosciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcadia Biosciences Cyclically Adjusted PS Ratio Chart

Arcadia Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.05

Arcadia Biosciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.05 0.04 0.05 0.05

Competitive Comparison of Arcadia Biosciences's Cyclically Adjusted PS Ratio

For the Packaged Foods subindustry, Arcadia Biosciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arcadia Biosciences's Cyclically Adjusted PS Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Arcadia Biosciences's Cyclically Adjusted PS Ratio falls into.



Arcadia Biosciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Arcadia Biosciences's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=6.30/53.05
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcadia Biosciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Arcadia Biosciences's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=1.127/133.0289*133.0289
=1.127

Current CPI (Sep. 2024) = 133.0289.

Arcadia Biosciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 68.244 99.070 91.637
201503 16.979 99.621 22.673
201506 47.667 100.684 62.980
201509 33.145 100.392 43.920
201512 24.473 99.792 32.624
201603 15.491 100.470 20.511
201606 13.109 101.688 17.149
201609 19.545 101.861 25.525
201612 9.643 101.863 12.593
201703 18.509 102.862 23.937
201706 18.698 103.349 24.068
201709 11.113 104.136 14.196
201712 26.943 104.011 34.460
201803 3.891 105.290 4.916
201806 5.253 106.317 6.573
201809 3.109 106.507 3.883
201812 3.700 105.998 4.644
201903 1.328 107.251 1.647
201906 1.611 108.070 1.983
201909 2.253 108.329 2.767
201912 1.917 108.420 2.352
202003 1.424 108.902 1.739
202006 1.206 108.767 1.475
202009 1.172 109.815 1.420
202012 25.647 109.897 31.045
202103 1.739 111.754 2.070
202106 2.583 114.631 2.998
202109 4.289 115.734 4.930
202112 3.912 117.630 4.424
202203 5.802 121.301 6.363
202206 6.951 125.017 7.396
202209 2.557 125.227 2.716
202212 1.104 125.222 1.173
202303 1.426 127.348 1.490
202306 0.955 128.729 0.987
202309 0.954 129.860 0.977
202312 1.214 129.419 1.248
202403 0.921 131.776 0.930
202406 0.958 132.554 0.961
202409 1.127 133.029 1.127

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Arcadia Biosciences  (NAS:RKDA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Arcadia Biosciences Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Arcadia Biosciences's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Arcadia Biosciences Business Description

Traded in Other Exchanges
Address
5950 Sherry Lane, Suite 215, Dallas, TX, USA, 75225
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water and others.
Executives
Thomas J. Schaefer officer: Chief Financial Officer 202 COUSTEAU PLACE STE 105, DAVIS CA 95618
Stanley Jr Jacot officer: Chief Executive Officer 202 COUSTEAU PLACE STE 105, DAVIS CA 95618
Pamela Haley officer: Chief Financial Officer 202 COUSTEAU PLACE, DAVIS CA 95618
Laura Pitlik officer: Chief Marketing Officer 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Chris Cuvelier officer: Chief Growth Officer 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Deborah D Carosella director 3603 HAVEN AVE, SUITE E, MENLO PARK CA 94025
Matthew T Plavan officer: Chief Financial Officer C/O THERMOGENESIS CORP., 2711 CITRUS ROAD, RANCHO CORDOVA CA 95742
Randall Shultz officer: Chief Technology Officer 4222 E. THOMAS ROAD, SUITE 320, PHOEBIIX AZ 85018
Sarah Reiter officer: Chief Commercial Officer 202 COUSTEAU PLACE, DAVIS CA 95618
Lilian Shackelford Murray director 228 BEACH ROAD, BELVEDERE CA 94920
Kevin Comcowich director C/O ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Albert D. Bolles director CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
Eric J. Rey director, officer: President and CEO ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Zhongjin Lu officer: VP Product Development ARCADIA BIOSCIENCES, INC., 202 COUSTEAU PLACE, SUITE 105, DAVIS CA 95618
Amy Yoder director C/O SPECTRUM BRANDS, INC., 6 CONCOURSE PARKWAY, SUITE 3300, ATLANTA GA 30328